Ieq Capital LLC Grows Stock Holdings in Walgreens Boots Alliance, Inc. $WBA

Key Points

• Ieq Capital LLC increased its stake in Walgreens Boots Alliance by 552.6%, holding 295,624 shares worth approximately $3.3 million as of the latest SEC filing.
• Several institutional investors, including Two Sigma Advisers LP and National Bank of Canada FI, significantly raised their stakes in Walgreens Boots Alliance, indicating increasing confidence in the company.
• Walgreens Boots Alliance reported an EPS of $0.38 for the last quarter, surpassing analyst expectations, alongside a revenue of $38.99 billion.

Ieq Capital LLC boosted its position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA - Free Report) by 552.6% during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 295,624 shares of the pharmacy operator's stock after purchasing an additional 250,326 shares during the period. Ieq Capital LLC's holdings in Walgreens Boots Alliance were worth $3,302,000 as of its most recent SEC filing.

Other large investors have also bought and sold shares of the company. Colonial Trust Co SC grew its stake in shares of Walgreens Boots Alliance by 79.5% during the 4th quarter. Colonial Trust Co SC now owns 2,928 shares of the pharmacy operator's stock worth $27,000 after acquiring an additional 1,297 shares during the period. Sentry Investment Management LLC purchased a new stake in Walgreens Boots Alliance during the first quarter valued at about $27,000. Curat Global LLC bought a new position in Walgreens Boots Alliance during the first quarter worth about $27,000. Federated Hermes Inc. increased its stake in shares of Walgreens Boots Alliance by 135.8% in the first quarter. Federated Hermes Inc. now owns 3,152 shares of the pharmacy operator's stock worth $35,000 after purchasing an additional 1,815 shares in the last quarter. Finally, N.E.W. Advisory Services LLC bought a new stake in shares of Walgreens Boots Alliance in the first quarter valued at approximately $43,000. 58.59% of the stock is owned by hedge funds and other institutional investors.

Walgreens Boots Alliance Price Performance

NASDAQ WBA remained flat at $11.98 on Thursday. The company's 50 day moving average price is $11.73 and its 200 day moving average price is $11.29. Walgreens Boots Alliance, Inc. has a 1-year low of $8.08 and a 1-year high of $13.25. The company has a debt-to-equity ratio of 0.96, a current ratio of 0.60 and a quick ratio of 0.32. The stock has a market cap of $10.37 billion, a price-to-earnings ratio of -1.64, a PEG ratio of 1.42 and a beta of 0.80.

Walgreens Boots Alliance (NASDAQ:WBA - Get Free Report) last posted its quarterly earnings data on Thursday, June 26th. The pharmacy operator reported $0.38 EPS for the quarter, topping the consensus estimate of $0.34 by $0.04. Walgreens Boots Alliance had a positive return on equity of 17.66% and a negative net margin of 4.07%.The firm had revenue of $38.99 billion for the quarter, compared to the consensus estimate of $36.72 billion. During the same quarter last year, the company earned $0.63 earnings per share. The business's revenue for the quarter was up 7.2% compared to the same quarter last year. On average, equities analysts expect that Walgreens Boots Alliance, Inc. will post 1.6 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

WBA has been the subject of a number of analyst reports. UBS Group reaffirmed a "neutral" rating on shares of Walgreens Boots Alliance in a report on Thursday, June 26th. Wall Street Zen assumed coverage on Walgreens Boots Alliance in a research note on Wednesday, May 21st. They issued a "hold" rating for the company. Finally, Morgan Stanley reiterated an "underweight" rating on shares of Walgreens Boots Alliance in a research report on Thursday, June 26th. One research analyst has rated the stock with a Buy rating, six have issued a Hold rating and four have given a Sell rating to the company's stock. According to data from MarketBeat, Walgreens Boots Alliance currently has an average rating of "Reduce" and a consensus price target of $10.15.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.